Royalty Pharma News

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 3 16:53 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 3 16:53 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 28 22:46 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 3 00:00 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 3 00:00 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 2 00:00 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 13, 2023 16:47 ET

Royalty Pharma | 424B3: Prospectus

Nov 16, 2023 17:13 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 3, 2023 16:15 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 3, 2023 16:15 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 9, 2023 16:45 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 12, 2023 16:47 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 3, 2023 16:16 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 3, 2023 16:15 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 2, 2023 16:35 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 2, 2023 16:31 ET

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

May 22, 2023 19:02 ET

Royalty Pharma | 424B3: Prospectus

Apr 15, 2022 16:18 ET

Royalty Pharma | 424B5: Prospectus

Jul 19, 2021 17:10 ET

Royalty Pharma | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jul 15, 2021 16:51 ET